Clinical and biochemical evaluations of the alga Spirulina with regard to its application in the treatment of obesity. A double-blind cross-over study

Extract: In a double-blind cross-over study vs placebo a supplemental dietary intake of 2.8 g of Spirulina thrice a day over a period of 4 weeks showed a small but statistically significant reduction of body weight in obese outpatients. Adverse effects on clinical variables (blood pressure, heart ra...

Full description

Saved in:
Bibliographic Details
Published inNutrition reports international (USA) Vol. 33; no. 4
Main Authors Becker, E.W, Jakober, B, Luft, D, Schmulling, R.M
Format Journal Article
LanguageEnglish
Published 01.04.1986
Subjects
DIETA TERAPEUTICA
PROTEINAS UNICELULARES
PROTEINE MICROBIOLOGIQUE
REGIME THERAPEUTIQUE
SAPROSPIRA
SOBREPESO
SURPOIDS
TERAPIA
THERAPEUTIQUE
Online AccessGet more information

Cover

More Information
Summary:Extract: In a double-blind cross-over study vs placebo a supplemental dietary intake of 2.8 g of Spirulina thrice a day over a period of 4 weeks showed a small but statistically significant reduction of body weight in obese outpatients. Adverse effects on clinical variables (blood pressure, heart rate) or biochemical variables (screening program including 32 parameters) were not detectable; relevant side effects were not observed.(author)
Bibliography:8706945
S30
ISSN:0029-6635